Background
China’s over-the-counter (OTC) drug market is enormous, with the size of 109.22 billion yuan (circa US$17.13 billion) in 2020. The market keeps gaining momentum due to the aging population and the growing healthcare awareness.The market access regulation on OTC drugs has eased a bit in recent years. In 2019 and 2021, China approved two pilot programs in Beijing and Henan, respectively, for importing over-the-counter (OTC) drugs through cross-border e-commerce (CBEC). Thus, CBEC emerges as a new opportunity for foreign OTC medicines to enter China.This webinar will introduce China’s OTC drug market and CBEC regulations. We recommend the article for understanding the topic better. For any related questions, please send them to customer@reach24h.com.
